News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News May 4, 2026
Gibson Dunn Acts as Financing Counsel to Long Lake Management on Acquisition of American Express Global Business Travel
Gibson Dunn is acting as financing counsel to General Catalyst-backed Long Lake Management on its acquisition of American Express Global Business Travel, a leading software and services company for travel, expense, and meetings and events.
Firm News April 2, 2026
Gibson Dunn Advises BVF Partners L.P. on up to $24.5 Million Financing for Entera Bio
Gibson Dunn represented BVF Partners L.P. in its up to $24.5 million private placement financing for Entera Bio Ltd., a clinical stage company focused on developing oral peptide and protein replacement therapies for significant unmet medical needs where an oral tablet form holds the potential to transform the standard of care.
Firm News March 10, 2026
Gibson Dunn Advises Coastlands Capital on up to $30 Million Financing for Longeveron Inc.
Gibson Dunn represented Coastlands Capital as lead investor in the up to $30 million private placement financing for Longeveron Inc., a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions.
Firm News March 9, 2026
Gibson Dunn Advises Coastlands Capital on up to $40 Million Financing for AN2 Therapeutics, Inc.
Gibson Dunn represented Coastlands Capital as lead investor in the up to $40 million private placement financing for AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform.
Client Alert February 27, 2026
Less Form, More Substance: 10 Things You Need to Know About the Proposed UK Securitisation Reforms
This briefing summarises the key changes and their implications for originators, sponsors and original lenders involved in securitisation transactions, with …
Firm News February 25, 2026
Gibson Dunn Advises BVF Partners L.P. on up to $400 Million Financing for Immunic, Inc.
Gibson Dunn represented BVF Partners L.P. as lead investor in the up to $400 million private placement financing for Immunic, Inc., a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases.
Firm News February 24, 2026
Gibson Dunn Advised Constellation Wealth Capital on Strategic Investment in BIP Wealth
Gibson Dunn advised Constellation Wealth Capital on its strategic investment in BIP Wealth, a Registered Investment Advisor headquartered in Atlanta with over $5.5 billion in assets under management.
Client Alert February 19, 2026
Key Themes and Takeaways from the FFA 2026 Global Fund Finance Symposium
Gibson Dunn’s market-leading Fund Finance & Structured Capital team participated in panel discussions and contributed to conversations on the evolution …